187 related articles for article (PubMed ID: 23389031)
1. Soluble melanoma cell adhesion molecule (sMCAM/sCD146) promotes angiogenic effects on endothelial progenitor cells through angiomotin.
Stalin J; Harhouri K; Hubert L; Subrini C; Lafitte D; Lissitzky JC; Elganfoud N; Robert S; Foucault-Bertaud A; Kaspi E; Sabatier F; Aurrand-Lions M; Bardin N; Holmgren L; Dignat-George F; Blot-Chabaud M
J Biol Chem; 2013 Mar; 288(13):8991-9000. PubMed ID: 23389031
[TBL] [Abstract][Full Text] [Related]
2. Soluble CD146 displays angiogenic properties and promotes neovascularization in experimental hind-limb ischemia.
Harhouri K; Kebir A; Guillet B; Foucault-Bertaud A; Voytenko S; Piercecchi-Marti MD; Berenguer C; Lamy E; Vely F; Pisano P; Ouafik L; Sabatier F; Sampol J; Bardin N; Dignat-George F; Blot-Chabaud M
Blood; 2010 May; 115(18):3843-51. PubMed ID: 20185588
[TBL] [Abstract][Full Text] [Related]
3. Targeting soluble CD146 with a neutralizing antibody inhibits vascularization, growth and survival of CD146-positive tumors.
Stalin J; Nollet M; Garigue P; Fernandez S; Vivancos L; Essaadi A; Muller A; Bachelier R; Foucault-Bertaud A; Fugazza L; Leroyer AS; Bardin N; Guillet B; Dignat-George F; Blot-Chabaud M
Oncogene; 2016 Oct; 35(42):5489-5500. PubMed ID: 27065325
[TBL] [Abstract][Full Text] [Related]
4. Angiomotin regulates endothelial cell-cell junctions and cell motility.
Bratt A; Birot O; Sinha I; Veitonmäki N; Aase K; Ernkvist M; Holmgren L
J Biol Chem; 2005 Oct; 280(41):34859-69. PubMed ID: 16043488
[TBL] [Abstract][Full Text] [Related]
5. Angiomotin: an angiostatin binding protein that regulates endothelial cell migration and tube formation.
Troyanovsky B; Levchenko T; Månsson G; Matvijenko O; Holmgren L
J Cell Biol; 2001 Mar; 152(6):1247-54. PubMed ID: 11257124
[TBL] [Abstract][Full Text] [Related]
6. Soluble CD146 boosts therapeutic effect of endothelial progenitors through proteolytic processing of short CD146 isoform.
Stalin J; Harhouri K; Hubert L; Garrigue P; Nollet M; Essaadi A; Muller A; Foucault-Bertaud A; Bachelier R; Sabatier F; Pisano P; Peiretti F; Leroyer AS; Guillet B; Bardin N; Dignat-George F; Blot-Chabaud M
Cardiovasc Res; 2016 Aug; 111(3):240-51. PubMed ID: 27170199
[TBL] [Abstract][Full Text] [Related]
7. Early prediction of revascularisation by angiomotin-targeting positron emission tomography.
Moyon A; Garrigue P; Balasse L; Fernandez S; Brige P; Nollet M; Hache G; Blot-Chabaud M; Dignat-George F; Guillet B
Theranostics; 2018; 8(18):4985-4994. PubMed ID: 30429881
[TBL] [Abstract][Full Text] [Related]
8. CD146/Soluble CD146 Pathway Is a Novel Biomarker of Angiogenesis and Inflammation in Proliferative Diabetic Retinopathy.
Abu El-Asrar AM; Nawaz MI; Ahmad A; Siddiquei MM; Allegaert E; Gikandi PW; De Hertogh G; Opdenakker G
Invest Ophthalmol Vis Sci; 2021 Jul; 62(9):32. PubMed ID: 34293080
[TBL] [Abstract][Full Text] [Related]
9. p130-angiomotin associates to actin and controls endothelial cell shape.
Ernkvist M; Aase K; Ukomadu C; Wohlschlegel J; Blackman R; Veitonmäki N; Bratt A; Dutta A; Holmgren L
FEBS J; 2006 May; 273(9):2000-11. PubMed ID: 16640563
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of angiomotin in sinonasal inverted papilloma.
Byun JY; Lee SH; Shin JM; Baek BJ; Lee JY
Int Forum Allergy Rhinol; 2014 Jun; 4(6):512-6. PubMed ID: 24532565
[TBL] [Abstract][Full Text] [Related]
11. Involvement of Multiple Variants of Soluble CD146 in Systemic Sclerosis: Identification of a Novel Profibrotic Factor.
Nollet M; Bachelier R; Joshkon A; Traboulsi W; Mahieux A; Moyon A; Muller A; Somasundaram I; Simoncini S; Peiretti F; Leroyer AS; Guillet B; Granel B; Dignat-George F; Bardin N; Foucault-Bertaud A; Blot-Chabaud M
Arthritis Rheumatol; 2022 Jun; 74(6):1027-1038. PubMed ID: 35001552
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic antibodies targeting angiomotin inhibit angiogenesis in vivo.
Levchenko T; Veitonmäki N; Lundkvist A; Gerhardt H; Ming Y; Berggren K; Kvanta A; Carlsson R; Holmgren L
FASEB J; 2008 Mar; 22(3):880-9. PubMed ID: 17984175
[TBL] [Abstract][Full Text] [Related]
13. Soluble form of the endothelial adhesion molecule CD146 binds preferentially CD16+ monocytes.
Garibaldi S; Barisione C; Ghigliotti G; Spallarossa P; Barsotti A; Fabbi P; Corsiglia L; Palmieri D; Palombo D; Brunelli C
Mol Biol Rep; 2012 Jun; 39(6):6745-52. PubMed ID: 22311021
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic targeting of soluble CD146/MCAM with the M2J-1 monoclonal antibody prevents metastasis development and procoagulant activity in CD146-positive invasive tumors.
Stalin J; Traboulsi W; Vivancos-Stalin L; Nollet M; Joshkon A; Bachelier R; Guillet B; Lacroix R; Foucault-Bertaud A; Leroyer AS; Dignat-George F; Bardin N; Blot-Chabaud M
Int J Cancer; 2020 Sep; 147(6):1666-1679. PubMed ID: 32022257
[TBL] [Abstract][Full Text] [Related]
15. Angiomotin p80/p130 ratio: a new indicator of exercise-induced angiogenic activity in skeletal muscles from obese and non-obese rats?
Roudier E; Chapados N; Decary S; Gineste C; Le Bel C; Lavoie JM; Bergeron R; Birot O
J Physiol; 2009 Aug; 587(Pt 16):4105-19. PubMed ID: 19546164
[TBL] [Abstract][Full Text] [Related]
16. Peptides derived from human decorin leucine-rich repeat 5 inhibit angiogenesis.
Sulochana KN; Fan H; Jois S; Subramanian V; Sun F; Kini RM; Ge R
J Biol Chem; 2005 Jul; 280(30):27935-48. PubMed ID: 15923192
[TBL] [Abstract][Full Text] [Related]
17. Augmentation of therapeutic angiogenesis using genetically modified human endothelial progenitor cells with altered glycogen synthase kinase-3beta activity.
Choi JH; Hur J; Yoon CH; Kim JH; Lee CS; Youn SW; Oh IY; Skurk C; Murohara T; Park YB; Walsh K; Kim HS
J Biol Chem; 2004 Nov; 279(47):49430-8. PubMed ID: 15339925
[TBL] [Abstract][Full Text] [Related]
18. Loss of responsiveness to chemotactic factors by deletion of the C-terminal protein interaction site of angiomotin.
Levchenko T; Aase K; Troyanovsky B; Bratt A; Holmgren L
J Cell Sci; 2003 Sep; 116(Pt 18):3803-10. PubMed ID: 12902404
[TBL] [Abstract][Full Text] [Related]
19. Soluble CD146 is increased in preeclampsia and interacts with galectin-1 to regulate trophoblast migration through VEGFR2 receptor.
Bouvier S; Traboulsi W; Blois SM; Demattei C; Joshkon A; Mousty E; Nollet M; Paulmyer-Lacroix O; Foucault-Bertaud A; Fortier M; Leroyer AS; Bachelier R; Letouzey V; Alfaidy N; Dignat-George F; Blot-Chabaud M; Gris JC; Bardin N
F S Sci; 2022 Feb; 3(1):84-94. PubMed ID: 35559998
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte colony-stimulating factor promotes neovascularization by releasing vascular endothelial growth factor from neutrophils.
Ohki Y; Heissig B; Sato Y; Akiyama H; Zhu Z; Hicklin DJ; Shimada K; Ogawa H; Daida H; Hattori K; Ohsaka A
FASEB J; 2005 Dec; 19(14):2005-7. PubMed ID: 16223785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
